Type 2 & Cardiovascular Risk (SURPASS)

Do you have Type 2 Diabetes?

We are testing an investigational medication for its effectiveness in treating Type 2 Diabetes in comparison with insulin. This study is focusing on people with an increased risk of cardiovascular events in particular.

Type 2 & Cardiovascular Risk (SURPASS)

Do you have Type 2 Diabetes?

We are testing an investigational medication for its effectiveness in treating Type 2 Diabetes in comparison with insulin. This study is focusing on people with an increased risk of cardiovascular events in particular.

In order to complete this study, we need volunteers from the public. You may be eligible for this study if you have:

  • Type 2 Diabetes
  • an HbA1c between 7.5-10.5%
  • an increased cardiovascular risk (eg: heart disease)
  • taking oral anti-hyperglycaemic medication (eg: metformin)

You will be medically supervised and there will be no costs involved. For more information, with no obligation, please call:

Kate – Clinical Research Coordinator (02) 4963 2323 (take option 1).
Please do leave a message with your name and contact details so we can return your call.

This study has Human Research Ethics Committee (HREC) approval.

Register Your Interest

Please contact us now to learn more about participating in this Clinical Trial.

Subscribe to Our Newsletter

Subscribe to Our Newsletter

x